| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
centrosomal protein 290 | 0.517 | 0.769 | 1.1E-60 |
|
disease | 0.400 | limited | 0 | 0 | |||||||||||
|
centrosomal protein 41 | 0.636 | 0.500 | 3.6E-06 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
ciliogenesis associated kinase 1 | 0.545 | 0.808 | 1.3E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cytoskeleton associated protein 2 like | 0.666 | 0.577 | 1.6E-04 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ciliogenesis and planar polarity effector 1 | 0.575 | 0.692 | 5.9E-36 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
centrosome and spindle pole associated protein 1 | 0.544 | 0.769 | 3.3E-29 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
DEAD-box helicase 59 | 0.650 | 0.423 | 5.9E-07 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
dynein cytoplasmic 2 heavy chain 1 | 0.555 | 0.731 | 1.1E-44 |
|
disease | 0.430 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
dynein cytoplasmic 2 light intermediate chain 1 | 0.601 | 0.500 | 3.2E-09 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
EBP cholestenol delta-isomerase | 0.494 | 0.846 | 0.94 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
EvC ciliary complex subunit 1 | 0.587 | 0.577 | 3.5E-25 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
EvC ciliary complex subunit 2 | 0.585 | 0.692 | 1.0E-34 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
fibroblast growth factor 10 | 0.530 | 0.692 | 0.94 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.310 | strong | 1.000 | 0 | 0 | 2005 | 2005 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
Fraser extracellular matrix complex subunit 1 | 0.560 | 0.577 | 3.1E-45 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
FRAS1 related extracellular matrix 2 | 0.566 | 0.577 | 3.6E-11 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
growth differentiation factor 5 | 0.511 | 0.692 | 0.67 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
GLI family zinc finger 2 | 0.446 | 0.846 | 0.97 |
|
disease | 0.430 | strong | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
GLI family zinc finger 3 | 0.436 | 0.846 | 1.00 |
|
disease | 0.700 | strong | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
glutamate receptor interacting protein 1 | 0.581 | 0.769 | 0.51 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
heterogeneous nuclear ribonucleoprotein K | 0.539 | 0.846 | 1.00 |
|
disease | 0.310 | moderate | 1.000 | 1 | 0 | 2009 | 2018 | ||||||||
|
homeobox A13 | 0.552 | 0.654 | 0.96 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 1997 | 1997 |